FDA greenlights phase 2 SURF302 trial of TYRA-300 in NMIBC
“We expect to initiate patient dosing in the second quarter of this year, with initial three-month [complete response] data to follow,” says Doug Warner.
Related Articles
Shreyas Joshi, MD, highlights initial promise from pivotal trial of EG-70
“We’re very much looking forward to the new data that’ll be presented, hopefully, within the next year, to see where this falls in the grand…
Testosterone Therapy May Not Up Prostate Cancer Recurrence Risk
Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
Adverse events were frequent, and most were gastrointestinal-related, including nausea, vomiting, diarrhea, constipation
Mark Edney, MD, on creating a collaborative culture with APPs in urology
“As long as APPs are properly supported, they will take off and they will change your practice,” says Mark T. Edney, MD.
EAU Guidelines on Chronic Pelvic Pain – MANAGEMENT – Uroweb
This guideline plays an important role in the process of consolidation and improvement of care for patients with abdominal and pelvic pain.
Patient-Centered Pathology Reports Improve Prostate Cancer Understanding
Benefits include better discrimination between risk levels
FDA clears chemiluminescence-based immunoassay for free testosterone
The test can provide results in 48 minutes to provide diagnostic insights for conditions such as hypogonadism, impotence, polycystic ovarian syndrome, and other androgenital syndromes.
Addressing Tumor-Specific Training Needs of the CNS in Uro-Oncology
The clinical nurse specialist in uro-oncology is undervalued and underdeveloped, according to a discussion paper on the role of this clinician.
Editorial Comment | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
CREST: Sasanlimab hits primary end point of EFS for NMIBC
Results from CREST will be presented at an upcoming medical conference.